In addition, a higher percentage of phosphorylated STAT6 (detected by proximity ligation assay) was found in the metastatic head and neck cancer samples (Fig. 7e, f), suggesting the activation of STAT6 in the metastatic tumors. This evidence concerns the gene STAT6 and head and neck cancer.